Skip to main content
. 2018 Oct 26;18:1043. doi: 10.1186/s12885-018-4959-4

Fig. 1.

Fig. 1

a and b Inhibition of cell growth in colorectal cancer. 3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyl tetrazoliumbromide assay was carried out on two colorectal cancer cell lines HCT116 and HT29 cells in order to gauge the effect of TAX and FH535 administration on growth of these colorectal cancer cell lines ***, P < 0.001 and **, P < 0.01 vs. control. % cell viability of HCT116 and HT29 cells were determined. c and d Inhibition of cologenecity in colorectal cancer cells by TAX (Clonogenic assay; 7 days). TAX administration (40 and 60 μM) of HCT116 and HT29 cells inhibiting colony formation. Each value represents a mean ± SD (n = 3)